Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Minerva Gastroenterologica E Dietologica|April 18, 2019
Helicobacter pylori and hematological disordersElisa Santambrogio, Lorella OrsucciClinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Update in indolent non-Hodgkin lymphoma (NHL): paradigm for Waldenström's macroglobulinemia (WM)Annalisa Chiappella, Chiara Ciochetto, Lorella Orsucci, et al.Cancer|September 21, 2004
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano LinformiFortunato Morabito, Andrea Gallamini, Caterina Stelitano, et al.Leukemia & Lymphoma|July 7, 2009
Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) studyMaria Giuseppina Cabras, Angela Maria Mamusa, Umberto Vitolo, et al.Leukemia & Lymphoma|September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphomaStefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.Annals of Hematology|April 18, 2018
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experienceChiara Ciochetto, Barbara Botto, Roberto Passera, et al.Journal of Personalized Medicine|April 3, 2021
Real Life Use of Bendamustine in Elderly Patients with Lymphoid NeoplasiaIrene Dogliotti, Simone Ragaini, Francesco Vassallo, et al.European Journal of Neurology|September 9, 2022
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-upMattia Parisi, Irene Dogliotti, Michele Clerico, et al.Clinical Lymphoma|July 13, 2004
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphomaAlessandro Levis, Daniela Pietrasanta, Laura Godio, et al.Haematologica|July 10, 2009
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter studyUmberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, et al.Pageof 4